3.87 USD
+0.14 (+3.75%)
3.87 USD
0 (0%)
We assign a fundamental rating of 3 out of 10 to ICAD. ICAD was compared to 34 industry peers in the Health Care Technology industry. No worries on liquidiy or solvency for ICAD as it has an excellent financial health rating, but there are worries on the profitability. ICAD has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year ICAD has reported negative net income.
- In the past year ICAD has reported a negative cash flow from operations.
- In the past 5 years ICAD always reported negative net income.
- In the past 5 years ICAD always reported negative operating cash flow.
1.2 Ratios
- The Return On Assets of ICAD (-13.24%) is comparable to the rest of the industry.
- ICAD has a better Return On Equity (-16.98%) than 61.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.24% | ||
| ROE | -16.98% | ||
| ROIC | N/A |
ROA(3y)-17.69%
ROA(5y)-20.57%
ROE(3y)-24.41%
ROE(5y)-31.02%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 85.57%, ICAD belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
- ICAD's Gross Margin has improved in the last couple of years.
- ICAD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 85.57% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.59%
GM growth 5Y1.87%
2. Health
2.1 Basic Checks
- ICAD does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for ICAD remains at a similar level compared to 1 year ago.
- The number of shares outstanding for ICAD has been increased compared to 5 years ago.
- ICAD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- ICAD has an Altman-Z score of -1.89. This is a bad value and indicates that ICAD is not financially healthy and even has some risk of bankruptcy.
- ICAD has a worse Altman-Z score (-1.89) than 69.44% of its industry peers.
- There is no outstanding debt for ICAD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.89 |
ROIC/WACCN/A
WACC10.6%
2.3 Liquidity
- A Current Ratio of 3.66 indicates that ICAD has no problem at all paying its short term obligations.
- With an excellent Current ratio value of 3.66, ICAD belongs to the best of the industry, outperforming 80.56% of the companies in the same industry.
- A Quick Ratio of 3.57 indicates that ICAD has no problem at all paying its short term obligations.
- The Quick ratio of ICAD (3.57) is better than 80.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.66 | ||
| Quick Ratio | 3.57 |
3. Growth
3.1 Past
- The earnings per share for ICAD have decreased strongly by -50.00% in the last year.
- Looking at the last year, ICAD shows a quite strong growth in Revenue. The Revenue has grown by 18.39% in the last year.
- Measured over the past years, ICAD shows a decrease in Revenue. The Revenue has been decreasing by -8.95% on average per year.
EPS 1Y (TTM)-50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)18.39%
Revenue growth 3Y-16.47%
Revenue growth 5Y-8.95%
Sales Q2Q%-1.61%
3.2 Future
- Based on estimates for the next years, ICAD will show a very strong growth in Earnings Per Share. The EPS will grow by 25.99% on average per year.
- Based on estimates for the next years, ICAD will show a small growth in Revenue. The Revenue will grow by 6.47% on average per year.
EPS Next Y12.57%
EPS Next 2Y20.06%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year4.66%
Revenue Next 2Y-2.38%
Revenue Next 3Y6.47%
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- ICAD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ICAD. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- ICAD's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.06%
EPS Next 3Y25.99%
5. Dividend
5.1 Amount
- No dividends for ICAD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ICAD INC / ICAD FAQ
What is the ChartMill fundamental rating of ICAD INC (ICAD) stock?
ChartMill assigns a fundamental rating of 3 / 10 to ICAD.
What is the valuation status of ICAD INC (ICAD) stock?
ChartMill assigns a valuation rating of 1 / 10 to ICAD INC (ICAD). This can be considered as Overvalued.
How profitable is ICAD INC (ICAD) stock?
ICAD INC (ICAD) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for ICAD stock?
The Earnings per Share (EPS) of ICAD INC (ICAD) is expected to grow by 12.57% in the next year.